Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.1K Hold
68,513
﹤0.01% 230
2026
Q1
$50.8K Hold
68,513
﹤0.01% 243
2025
Q4
$92.5K Hold
68,513
﹤0.01% 202
2025
Q3
$82.9K Hold
68,513
﹤0.01% 201
2025
Q2
$61.1K Buy
+68,513
New +$89.9K ﹤0.01% 192

Other funds holding YCBD

Alesco Advisors's YCBD Position: Q2 2026 in Review

Alesco Advisors held its cbdMD (YCBD) position steady in Q2 2026 at 68,513 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Alesco Advisors first reported a position in YCBD in Q2 2025 and has held it in 5 quarters since. The position peaked at $92.5K in Q4 2025. 27 funds tracked by Wall St. Rank hold YCBD as of Q2 2026.

  • Alesco Advisors held 68,513 shares of cbdMD worth $46.1K as of Q2 2026.
  • Alesco Advisors left its cbdMD share count unchanged in Q2 2026.
  • cbdMD made up ﹤0.01% of Alesco Advisors's portfolio in Q2 2026, its #230 holding.
  • Alesco Advisors first reported a position in cbdMD in Q2 2025 and has held it in 5 quarters since.
  • Alesco Advisors's cbdMD position peaked at $92.5K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held cbdMD as of Q2 2026.

Based on Alesco Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.